{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220916",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 10",
          "submission_class_code_description": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
          "application_docs": [
            {
              "id": "72108",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/216457Orig1s000ltr.pdf",
              "date": "20220919",
              "type": "Letter"
            },
            {
              "id": "72116",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216457s000lbl.pdf",
              "date": "20220920",
              "type": "Label"
            },
            {
              "id": "74686",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/216457Orig1s000TOC.html",
              "date": "20230703",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20240305",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "77718",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216457Orig1s003ltr.pdf",
              "date": "20240305",
              "type": "Letter"
            },
            {
              "id": "77722",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216457Orig1s003lbl.pdf",
              "date": "20240305",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA216457",
      "sponsor_name": "HERON THERAPS INC",
      "openfda": {
        "application_number": [
          "NDA216457"
        ],
        "brand_name": [
          "APONVIE"
        ],
        "generic_name": [
          "APREPITANT"
        ],
        "manufacturer_name": [
          "Heron Therapeutics, Inc."
        ],
        "product_ndc": [
          "47426-401"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "APREPITANT"
        ],
        "rxcui": [
          "2631783",
          "2631788"
        ],
        "spl_id": [
          "aeb8e76c-6054-4324-8f4f-bfdcf9ce4856"
        ],
        "spl_set_id": [
          "d1b111eb-659a-496b-a86a-8f0fa370f147"
        ],
        "package_ndc": [
          "47426-401-01",
          "47426-401-10"
        ],
        "nui": [
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185507",
          "N0000185506"
        ],
        "pharm_class_moa": [
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "pharm_class_epc": [
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "1NF15YR6UY"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "APONVIE",
          "active_ingredients": [
            {
              "name": "APREPITANT",
              "strength": "32MG/4.4ML (7.2MG/ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "EMULSION",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}